The DOI matches its Crossref record; 1,858 of the 1,862 references it cites were found in a registry or an index.
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Open accessAbstract
This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in up- and downregulation of hundreds of genes. An understanding of these changes is crucial for a correct interpretation of in vitro data. The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver. Also discussed is how closely hepatoma, stem cell and iPS cell-derived hepatocyte-like-cells resemble real hepatocytes. Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity. One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation. Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures








![Fig. 9 Antiproteolytic effect of acetaldehyde in the single pass perfused rat liver. a Acetaldehyde (5 mmol/l) was infused into the perfused liver for 30 min, and the release of [3H]leucine from pre-labeled rats was taken as a measure of proteolysis. b The resulting inhibition of proteolysis under steady-state conditions at different concentrations of acetaldehyde. Data are from 2 to 4 different experiments and are given as mean ± SEM. From vom Dahl and Häussinger (1998)](/paper-figures/2844bb4a493e46429af445399835e22f/recent-advances-in-2d-and-3d-in-vitro-systems-using-primary-hepatocytes-figure-9.jpg)
















































Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Already in the first few days of cultivation, a reduction of hepatic functions can be observed, e.g. production of plasma proteins, drug metabolizing enzyme activities, glucose metabolism and urea synthesis (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary human hepatocytes (PHHs) are an important tool for studying human liver disease and drug-induced liver injury (DILI), with other models, such as rat hepatocytes, hepatic cell lines and stem cell-derived hepatocyte-like cells failing to offer metabolically competent and species-relevant alternatives (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, zonation appears to be a large influencing factor on variation during culture as our pathway analysis of the most variable proteins revealed significant association with ketogenesis, cholesterol biosynthesis, fatty acid β oxidation and glutamine synthesis (table S4), all of these are related to the portocentral axis gradient of the lobule (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“although cytotoxicity measures are fundamental in the assessment of a drug’s potential for hepatotoxicity in vitro33,34, gene expression and various phenotypic changes can occur at much lower concentrations35,36.”
From Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology (2022) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“The apical membrane is equipped with transport proteins that eliminate bile acids and xenobiotics from the cell, like multidrug resistance-associated protein 2 (MRP2) (Godoy et al., 2013[15]; Ito et al., 2005[20]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The hepatocyte's basal membrane faces the sinusoid. It expresses several transmembrane transporters that manage the exchange of substances with the sinusoidal blood stream (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“In vivo, the distribution of ECM components varies between the different parts of the liver acinus, the smallest organizational unit of the liver (Godoy et al., 2013[15]; Martinez-Hernandez and Amenta, 1993[26]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In practice, strategies for optimizing HepG2 can be divided into several approaches. The first approach is based on genetic modification of cells to express key biotransformation enzymes, in particular cytochrome P450 isoforms [109]. The second approach involves epigenetic and cultural maturation of cells, which allows for increased expression of nuclear receptors and, consequently, of xenobiotic”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [163]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Wheat proteins improve cryopreservation of rat hepatocytes
Grondin, M., Hamel, F., Averill‐Bates, D. A., & Sarhan, F. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22270 · Cited by 18
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Computer Simulation of Liquids
Allen, M. P., & Tildesley, D. J. (2017) · doi:10.1093/oso/9780198803195.001.0001 · Cited by 20,945
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Computer Simulation of Liquids
P, S., & J, K. (1988) · Journal of Molecular Liquids · doi:10.1016/0167-7322(88)80022-9 · Cited by 16,088
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Two-photon laser scanning fluorescence microscopy
Denk, W., Strickler, J. H., & Webb, W. W. (1990) · Science · doi:10.1126/science.2321027 · Cited by 9,488
Research works printed but not linked: 9
- Bode JG (2011) Inflammation and liver regeneration. In: Häussinger D (ed) Liver regneration. DeGruyter Verlag, Berlin
- Bücher T, Sies H (1976) Mitochondrial and cytosolic redox states in perfused rat liver: methods and problems in metabolic compartmentation. In: Tager jm WJ, Söling D (eds) Use of isolated liver cells and kidney tubules in metabolic studies. North Holland Publishing Company/American Elsevier, New York/Amsterdam
- EPA (2012) EPA’s reanalysis of key issues related to dioxin toxicity and response to NAS Comments. Environmental Protection Agency (EPA), Washington, DC
- Hallifax D, Foster JA, Houston JB (2010) Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Pharm Res 27:2150–2161 · DOI
- ITC (International Transporter Consortium) (2010) Membrane transporters in drug development (Report from the FDA Critical Path Workshop). Nat Rev Drug Discov 9:215–236 · DOI · Paper page
- Lamers W, Moorman A, Charles R (1989) The metabolic lobulus, a key to the architecture of the liver. In: Revisiones Sobre Biologia Celular, Springer, New York
- Sahin S (2003) Perfused liver preparation and its applications. FABAD J Pharm Sci 28:39–49
- Waddington CH (1942) The epigenotype. Endeavour 1:18–20
- Warburg O (1923) Versuche an überlebendem Karzinomgewebe. Biochem Z 142:317
Cited by
Sorted by citations
Items 401–500 of 1,002
Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk?
Kenna, J. G., & Uetrecht, J. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082719 · Cited by 31
Jiang, J., Pieterman, C., Ertaylan, G., Peeters, R., & de Kok, T. M. C. M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02585-5 · Cited by 32
Sun, B., Liang, Z., Wang, Y., Yu, Y., Zhou, X., Geng, X., & Li, B. (2024) · Toxicology · doi:10.1016/j.tox.2024.153829 · Cited by 30
Hepatic Bile Acid Transporters and Drug-induced Hepatotoxicity
Saran, C., & Brouwer, K. L. R. (2023) · Toxicologic Pathology · doi:10.1177/01926233231212255 · Cited by 30
Bachmann, M., Waibler, Z., Pleli, T., Pfeilschifter, J. M., & Mühl, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00890 · Cited by 30
Assessment of stem cell differentiation based on genome-wide expression profiles
Godoy, P., Schmidt‐Heck, W., Hellwig, B., Nell, P., Feuerborn, D., Rahnenführer, J., Kattler, K., Walter, J., Blüthgen, N., & Hengstler, J. G. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0221 · Cited by 31
Self-citationRaasch, M., Fritsche, E., Kurtz, A., Bauer, M. W., & Mosig, A. S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.008 · Cited by 30
Superoxide dismutase response and the underlying molecular mechanism induced by iodoacetic acid
Wang, J., Jia, R., Zheng, X., Liu, R., & Zong, W. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.06.108 · Cited by 30
Transforming the spleen into a liver-like organ in vivo
Wang, L., Wang, C., Wang, Z., Gan, J., Liu, C., Xia, S., Niu, Y., Chen, D., Zhang, J., & Dong, L. (2020) · Science Advances · doi:10.1126/sciadv.aaz9974 · Cited by 30
Al‐Dhamin, Z., Liu, L., Li, D., Zhang, S., Dong, S., & Nan, Y. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i47.7444 · Cited by 30
Customizable Microfluidic Origami Liver‐on‐a‐Chip (oLOC)
Xie, X., Maharjan, S., Kelly, C. M., Liu, T., Lang, R. J., Alperin, R. C., Sebastian, S., Bonilla, D., Gandolfo, S., Boukataya, Y., et al. (2021) · Advanced Materials Technologies · doi:10.1002/admt.202100677 · Cited by 30
Limonciel, A., Mönks, K., Stanzel, S. F., Truisi, G. L., Parmentier, C., Aschauer, L., Wilmes, A., Richert, L., Hewitt, P. G., Mueller, S. O., et al. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.12.011 · Cited by 29
Self-citationWang, J., Wang, J., Zhang, L., Liu, R., & Zong, W. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b00291 · Cited by 29
Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases
Maepa, W., & Ndlovu, H. (2020) · Stem Cells · doi:10.1002/stem.3154 · Cited by 29
The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases
Nikokiraki, C., Psaraki, A., & Roubelakis, M. G. (2022) · Cells · doi:10.3390/cells11091410 · Cited by 29
Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix
Messelmani, T., Goff, A. L., Souguir, Z., Maes, V., Roudaut, M., Vandenhaute, E., Maubon, N., Legallais, C., Leclerc, É., & Jellali, R. (2022) · Bioengineering · doi:10.3390/bioengineering9090443 · Cited by 31
Roth, A., Lama, P., Dunn, S. P., Hong, S., & Lee, M. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.04.092 · Cited by 29
Application of hepatocyte-like cells to enhance hepatic safety risk assessment in drug discovery
Williams, D. P. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0228 · Cited by 29
Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization
Ashraf, M. N., Asghar, M. W., Rong, Y., Doschak, M. R., & Kiang, T. K. L. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0533-3 · Cited by 29
Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism
Zhang, L., Yao, W., Xia, J., Wang, T., & Huang, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081885 · Cited by 30
Investigating acetaminophen hepatotoxicity in multi-cellular organotypic liver models
Orbach, S. M., Cassin, M. E., Ehrich, M. F., & Rajagopalan, P. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.03.008 · Cited by 28
Mun, S. J., Hong, Y.-H., Shin, Y., Lee, J., Cho, H.-S., Kim, D.-S., Chung, K.-S., & Son, M. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-50250-w · Cited by 28
Gál, Z., Hegedüs, C., Szakács, G., Váradi, A., Sarkadi, B., & Özvegy‐Laczka, C. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.11.006 · Cited by 28
In Vitro Intestinal and Liver Models for Toxicity Testing
Orbach, S. M., Less, R. R., Kothari, A., & Rajagopalan, P. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00699 · Cited by 30
Lipidomic profiling of patient-specific induced pluripotent stem cell-derived hepatocyte-like cells
Kiamehr, M., Viiri, L. E., Vihervaara, T., Koistinen, K. M., Hilvo, M., Ekroos, K., Käkelä, R., & Aalto‐Setälä, K. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030841 · Cited by 28
RefiningIn VitroToxicity Models: Comparing Baseline Characteristics of Lung Cell Types
Lujan, H., Criscitiello, M. F., Hering, A. S., & Sayes, C. M. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz001 · Cited by 29
Wang, X., Li, L., Wang, H., Xiao, F., & Ning, Q. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12791 · Cited by 28
Salter, D. M., Wei, W., Nahar, P. P., Marques, E., & Slitt, A. L. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab043 · Cited by 28
Sekar, R., Motzler, K., Kwon, Y., Novikoff, A., Jülg, J., Najafi, B., Wang, S., Warnke, A.-L., Seitz, S., Hass, D., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.022 · Cited by 30
In vitro 3D Spheroids and Microtissues: ATP-based Cell Viability and Toxicity Assays
Kijańska, M., & Kelm, J. M. (2016) · Europe PMC (PubMed Central) · Cited by 28
Self-citationGranitzny, A., Knebel, J., Schaudien, D., Braun, A. C., Steinberg, P., Dasenbrock, C., & Hansen, T. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.05.001 · Cited by 28
A simple approach for restoration of differentiation and function in cryopreserved human hepatocytes
Ölander, M., Wiśniewski, J. R., Flörkemeier, I., Handin, N., Urdzik, J., & Artursson, P. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2375-9 · Cited by 30
Hepatocyte Concentrations of Indocyanine Green Reflect Transfer Rates Across Membrane Transporters
Cusin, F., Azevedo, L. F., Bonnaventure, P., Desmeules, J. A., Daali, Y., & Pastor, C. M. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12671 · Cited by 27
Ware, B. R., McVay, M., Sunada, W. Y., & Khetani, S. R. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx059 · Cited by 27
Image-Based Quantification of Cell Debris as a Measure of Apoptosis
Ölander, M., Handin, N., & Artursson, P. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01243 · Cited by 27
A 3D Human Liver Model of Nonalcoholic Steatohepatitis
Duriez, M., Jacquet, A., Hoet, L., Roche, S., Bock, M., Rocher, C., Haussy, G., Vigé, X., Böcskei, Z., Slavnic, T., et al. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00015 · Cited by 27
Kato, Y., Lim, A. Y., Sakolish, C., Valdiviezo, A., Moyer, H. L., Hewitt, P. G., Bajaj, P., Han, G., & Rusyn, I. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105464 · Cited by 27
Self-citationAdverse effects and underlying mechanism of amorphous silica nanoparticles in liver
Liang, Q., Sun, M., Ma, Y., Wang, F., Sun, Z., & Duan, J. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136955 · Cited by 27
Pervin, M., Golbar, H. M., Bondoc, A., Izawa, T., Kuwamura, M., & Yamate, J. (2015) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2015.11.003 · Cited by 27
Hrouzek, P., Kapuścik, A., Vacek, J., Voráčová, K., Paichlová, J., Kosina, P., Voloshko, L. N., Ventura, S., & Kopecký, J. (2015) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2015.10.020 · Cited by 27
Tachikawa, M., Sumiyoshiya, Y., Saigusa, D., Sasaki, K., Watanabe, M., Uchida, Y., & Terasaki, T. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.079244 · Cited by 27
CRUP: a comprehensive framework to predict condition-specific regulatory units
Ramisch, A., Heinrich, V., Glaser, L. V., Fuchs, A., Yang, X., Benner, P., Schöpflin, R., Li, N., Kinkley, S., Römer-Hillmann, A., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1860-7 · Cited by 29
Self-citationKermanizadeh, A., Berthing, T., Guzniczak, E., Wheeldon, M., Whyte, G., Vogel, U. B., Moritz, W., & Stone, V. (2019) · Particle and Fibre Toxicology · doi:10.1186/s12989-019-0326-0 · Cited by 27
Contribution to the ongoing discussion on fluoride toxicity
Guth, S., Hüser, S., Roth, A., Degen, G. H., Diel, P. R., Edlund, K., Eisenbrand, G., Engel, K., Epe, B., Grune, T., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03072-6 · Cited by 27
Self-citationGuraka, A., Souch, G., Duff, R. H., Brown, D., Moritz, W., & Kermanizadeh, A. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143032 · Cited by 27
Hu, W., Wang, Y., Han, J., Zhang, W., Chen, J., Li, X., & Wang, L. (2025) · Biomaterials Science · doi:10.1039/d4bm01273a · Cited by 27
Advances in 2D and 3D in vitro systems for hepatotoxicity testing
Hammad, S. (2013) · EXCLI journal · doi:10.17877/de290r-7355 · Cited by 26
Self-citationDistribution of SiO2 nanoparticles in 3D liver microtissues
Fleddermann, J., Susewind, J., Peuschel, H., Koch, M., Tavernaro, I., & Kraegeloh, A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s189888 · Cited by 26
Emerging trends in modeling human liver disease in vitro
Underhill, G. H., & Khetani, S. R. (2019) · APL Bioengineering · doi:10.1063/1.5119090 · Cited by 26
Brecklinghaus, T., Albrecht, W., Kappenberg, F., Duda, J., Vartak, N., Edlund, K., Marchan, R., Ghallab, A., Cadenas, C., Günther, G., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109728 · Cited by 26
Self-citationEckstrum, K., Striz, A., Ferguson, M. S., Zhao, Y., & Sprando, R. L. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112828 · Cited by 26
TSC22D4 interacts with Akt1 to regulate glucose metabolism
Demir, S., Wolff, G., Wieder, A., Maida, A., Bühler, L., Brune, M., Hautzinger, O., Feuchtinger, A., Poth, T., Szendroedi, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo5555 · Cited by 27
MicroRNAs as key mediators of hepatic detoxification
Chen, Y., Xiao, J., Zhang, X., & Bian, X. (2016) · Toxicology · doi:10.1016/j.tox.2016.08.005 · Cited by 27
Gómez-Lechón, M. J., Tolosa, L., & Donato, M. T. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1238459 · Cited by 26
Self-citationWang, Q., Chou, X., Guan, F., Fang, Z., Lu, S., Lei, J., Li, Y., & Liu, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-00377-4 · Cited by 26
McMullen, P. D., Pendse, S. N., Black, M. B., Mansouri, K., Haider, S., Andersen, M. E., & Clewell, R. A. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.02.014 · Cited by 27
Self-citationThe Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review
Özkan, A., Stolley, D. L., Cressman, E. N. K., McMillin, M., DeMorrow, S., Yankeelov, T. E., & Rylander, M. N. (2020) · Micromachines · doi:10.3390/mi11050487 · Cited by 28
In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist
Vinken, M. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2201-4 · Cited by 26
Self-citationIn vitro-ex vivo model systems for nanosafety assessment
Wick, P., Chortarea, S., Guenat, O. T., Roesslein, M., Stucki, J. D., Hirn, S., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2015) · European Journal of Nanomedicine · doi:10.1515/ejnm-2014-0049 · Cited by 26
Hammad, S., Braeuning, A., Meyer, C., Mohamed, F. E. Z. A., Hengstler, J. G., & Dooley, S. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2040-8 · Cited by 25
Self-citationPanel), E. P. O. P. P. P. A. T. R. (. P., Hernández, A. F., Adriaanse, P., Aldrich, A., Berny, P. J., Čoja, T., Duquesne, S., Focks, A., Marinovich, M., Millet, M., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6970 · Cited by 25
Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease
Fisher, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15070 · Cited by 25
Miyazaki, H., & Takezawa, T. (2015) · Cytotechnology · doi:10.1007/s10616-015-9934-1 · Cited by 25
Technological advancements for the development of stem cell-based models for hepatotoxicity testing
Natale, A., Vanmol, K., Arslan, A., Vlierberghe, S. V., Dubruel, P., Erps, J. V., Hugo Thienpont, A., Buzgo, M., Boeckmans, J., Kock, J. D., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02465-y · Cited by 25
Self-citationMicrofluidic systems for modeling digestive cancer: a review of recent progress
Razavi, Z., Soltani, M., Pazoki-Toroudi, H., & Dabagh, M. (2024) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ad6f15 · Cited by 24
Long-term culture of primary hepatocytes: new matrices and microfluidic devices
Burkhardt, B., Martinez-Sanchez, J. J., Bachmann, A., Ladurner, R., & Nussler, A. K. (2013) · Hepatology International · doi:10.1007/s12072-013-9487-3 · Cited by 24
Self-citationMoreno‐Torres, M., García-Llorens, G., Moro, E., Méndez, R., Quintás‐Cardama, A., & Castell, J. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-01652-1 · Cited by 24
Li, J., Diamante, G., Ahn, I. S., Wijaya, D., Wang, X., Chang, C. H., Ha, S. M., Immadisetty, K., Meng, H., Nel, A. E., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101652 · Cited by 24
Segovia‐Zafra, A., Paz, M. V., Serras, A. S., Matilla‐Cabello, G., Bodoque-García, A., Zeo-Sánchez, D. E. D., Niu, H., Álvarez‐Álvarez, I., Sanz‐Villanueva, L., Godec, S., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.026 · Cited by 24
Szalowska, E., Tesfay, H. A., van Hijum, S. V., & Kersten, S. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-1106 · Cited by 24
Toivonen, S., Malinen, M. M., Küblbeck, J., Petsalo, A., Urtti, A. O., Honkakoski, P., & Otonkoski, T. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0127 · Cited by 24
Smith, A. A., Petersen, B. K., Ropella, G. E. P., Kennedy, R., Kaplowitz, N., Ookhtens, M., & Hunt, C. A. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005253 · Cited by 24
Lin, C., & Khetani, S. R. (2017) · Current Protocols in Toxicology · doi:10.1002/cptx.23 · Cited by 24
Effects of diosmetin on nine cytochrome P450 isoforms, UGTs and three drug transporters in vitro
Chen, J., Zhang, J., Zhang, X.-Q., Qi, M., Shi, M., Yang, J., Zhang, K.-Z., Guo, C., & Han, Y. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.08.020 · Cited by 24
Satoh, D., Abe, S., Kobayashi, K., Nakajima, Y., Oshimura, M., & Kazuki, Y. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.01.002 · Cited by 25
Docci, L., Parrott, N. J., Krähenbühl, S., & Fowler, S. M. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219831407 · Cited by 24
Ackerson, T. J., Amberg, A., Atzrodt, J., Arabeyre‐Fabre, C., Defoßa, E., Dorau, M., Dudda, A., Dwyer, J., Holla, W., Kissner, T., et al. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22345 · Cited by 24
Su, S., Poto, C. D., Roy, R., Liu, X., Cui, W., Kroemer, A., & Ressom, H. W. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219855398 · Cited by 24
A microfluidic thyroid-liver platform to assess chemical safety in humans
Kuehnlenz, J. (2022) · ALTEX · doi:10.14573/altex.2108261 · Cited by 26
Liu, J., Li, R., Xue, R., Li, T., Leng, L., Wang, Y., Wang, J., Ma, J., Yan, J., Yan, F., et al. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800110 · Cited by 23
Advances in liver and pancreas organoids: how far we have come and where we go next
Sljukic, A., Jenkinson, J. G., Niksic, A., Prior, N., & Huch, M. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01116-1 · Cited by 25
Kim, H.-M., Kim, J., Choi, Y., Chun, H., Im, I., Han, Y., Song, C., Yoon, S., & Park, H. (2016) · Scientific Reports · doi:10.1038/srep21684 · Cited by 23
Self-citationSalman, M. M. A., Kotb, A. M., Haridy, M., & Hammad, S. (2016) · EXCLI journal · doi:10.17179/excli2016-777 · Cited by 23
Self-citationWang, Z., Li, W., Li, Q., Jing, H., Yuan, T., Fu, G., Tang, D., Zhang, H., Yan, H., & Zhai, B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109010 · Cited by 23
Nakai, S., Shibata, I., Shitamichi, T., Yamaguchi, H., Takagi, N., Inoue, T., Nakagawa, T., Kiyokawa, J., Wakabayashi, S., Miyoshi, T., et al. (2019) · Biology Open · doi:10.1242/bio.042192 · Cited by 24
Organ bioprinting: progress, challenges and outlook
Wu, Y. B., Qin, M., & Yang, X. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb01630g · Cited by 24
Fish cell line: depositories, web resources and future applications
Kumar, S., Singh, V. K., Mishra, A. K., Kushwaha, B., Kumar, R., & Lal, K. K. (2023) · Cytotechnology · doi:10.1007/s10616-023-00601-2 · Cited by 23
TECHNOLOGIES OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
Sevastianov, V. I. (2014) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2014-3-93-108 · Cited by 23
Isolation and Culture of Single Cell Types from Rat Liver
Zhang, Q., Qu, Y., Li, Z., Zhang, Q., Xu, M., Cai, X., Li, F., & Lu, L. (2016) · Cells Tissues Organs · doi:10.1159/000444672 · Cited by 23
Hoehme, S., Bertaux, F., Weens, W., Grasl‐Kraupp, B., Hengstler, J. G., & Drasdo, D. (2018) · Bulletin of Mathematical Biology · doi:10.1007/s11538-017-0375-1 · Cited by 23
Self-citationCuykx, M., Negreira, N., Beirnaert, C., den Eede, N. V., Rodrigues, R. M., Vanhaecke, T., Laukens, K., & Covaci, A. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.01.050 · Cited by 23
Self-citationTakemura, A., Izaki, A., Sekine, S., & Ito, K. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.05.016 · Cited by 23
Self-citationOxygen Gradient Induced in Microfluidic Chips Can Be Used as a Model for Liver Zonation
Ghafoory, S., Stengl, C., Kopany, S., Mayadag, M., Mechtel, N., Murphy, B., Schattschneider, S., Wilhelmi, N., & Wölfl, S. (2022) · Cells · doi:10.3390/cells11233734 · Cited by 22
Sex hormones differently regulate lipid metabolism genes in primary human hepatocytes
Seidemann, L., Lippold, C. P., Rohm, C. M., Eckel, J. C., Schicht, G., Matz‐Soja, M., Berg, T., Seehofer, D., & Damm, G. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01663-9 · Cited by 22
Self-citationBounakta, S., Bteich, M., Mantha, M., Poulin, P., & Haddad, S. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1294276 · Cited by 22
Wang, X., Moore, M. P., Shi, H., Miyata, Y., Donnelly, S. K., Radiloff, D. R., & Tabas, I. (2023) · Molecular Therapy Methods & Clinical Development · doi:10.1016/j.omtm.2023.101165 · Cited by 21
Pink, M., Ratsch, B. A., Mardahl, M., Durek, P., Polansky, J. K., Karl, M., Baumgrass, R., Wallner, S., Cadenas, C., Gianmoena, K., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502434 · Cited by 22
Large‐scale computational models of liver metabolism: How far from the clinics?
Tomaš, T. C., Reichert, M., Moškon, M., Mraz, M., Lammert, F., & Rozman, D. (2017) · Hepatology · doi:10.1002/hep.29268 · Cited by 22
Huang, S.-C., Li, L., Rehman, M. U., Gao, J., Zhang, L., Tong, X., Waqas, M., & Li, J. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-06664-z · Cited by 22
Weiß, T. S., Lupke, M., Dayoub, R., Geissler, E. K., Schlitt, H. J., Melter, M., & Eggenhofer, E. (2019) · Cells · doi:10.3390/cells8111421 · Cited by 22
Metadata
- Authors
- Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., Braeuning, A., Budinsky, R. A., Burkhardt, B., Cameron, N. R., Camussi, G., Cho, C.-S., Choi, Y.-J., Craig Rowlands, J., Dahmen, U., Damm, G., Dirsch, O., Donato, M. T., Dong, J., Dooley, S., Drasdo, D., Eakins, R., Ferreira, K. S., Fonsato, V., Fraczek, J., Gebhardt, R., Gibson, A., Glanemann, M., Goldring, C. E. P., Gómez-Lechón, M. J., Groothuis, G. M. M., Gustavsson, L., Guyot, C., Hallifax, D., Hammad, S., Hayward, A., Häussinger, D., Hellerbrand, C., Hewitt, P., Hoehme, S., Holzhütter, H.-G., Houston, J. B., Hrach, J., Ito, K., Jaeschke, H., Keitel, V., Kelm, J. M., Kevin Park, B., Kordes, C., Kullak-Ublick, G. A., LeCluyse, E. L., Lu, P., Luebke-Wheeler, J., Lutz, A., Maltman, D. J., Matz-Soja, M., McMullen, P., Merfort, I., Messner, S., Meyer, C., Mwinyi, J., Naisbitt, D. J., Nussler, A. K., Olinga, P., Pampaloni, F., Pi, J., Pluta, L., Przyborski, S. A., Ramachandran, A., Rogiers, V., Rowe, C., Schelcher, C., Schmich, K., Schwarz, M., Singh, B., Stelzer, E. H. K., Stieger, B., Stöber, R., Sugiyama, Y., Tetta, C., Thasler, W. E., Vanhaecke, T., Vinken, M., Weiss, T. S., Widera, A., Woods, C. G., Xu, J. J., Yarborough, K. M., & Hengstler, J. G.
- Affiliations
- University of Zurich (CH)
- Leibniz Research Centre for Working Environment and Human Factors (DE)
- The Hamner Institutes for Health Sciences (US)
- Goethe University Frankfurt (DE)
- Vrije Universiteit Brussel (BE)
- University of Freiburg (DE)
- Leipzig University (DE)
- Dow Chemical (United States) (US)
- Durham University (GB)
- Seoul National University (KR)
- Instituto de Investigación Sanitaria La Fe (ES)
- Heidelberg University (DE)
- University of Liverpool (GB)
- University of Groningen (NL)
- Lund University (SE)
- University of Manchester (GB)
- South Valley University (EG)
- Heinrich Heine University Düsseldorf (DE)
- University Hospital Regensburg (DE)
- Merck KGaA, Darmstadt (Germany) (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Musashino University (JP)
- University Hospital Zurich (CH)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Hewitt, Nicola J.
- ORCID
- Hewitt, Nicola J.
- Andersen, Melvin E.
- Bhattacharya, Sudin
- Bode, Johannes Georg
- Borner, Christoph
- Böttger, Jan
- Braeuning, Albert
- Budinsky, Robert A.
- Cameron, Neil R.
- Camussi, Giovanni
- Cho, Chong-Su
- Choi, Yun-Jaie
- Dahmen, Uta
- Damm, Georg
- Dirsch, Olaf
- Donato, María Teresa
- Dong, Jian
- Dooley, Steven
- Drasdo, Dirk
- Gibson, Andrew
- Glanemann, Matthias
- Groothuis, Geny M. M.
- Hallifax, David
- Hammad, Seddik
- Hayward, Adam
- Häussinger, Dieter
- Hellerbrand, Claus
- Hewitt, Philip
- Hoehme, Stefan
- Holzhütter, Hermann-Georg
- Houston, J. Brian
- Ito, Kiyomi
- Jaeschke, Hartmut
- Keitel, Verena
- Kordes, Claus
- Kullak-Ublick, Gerd A.
- LeCluyse, Edward L.
- Maltman, Daniel J.
- McMullen, Patrick
- Merfort, Irmgard
- Meyer, Christoph
- Mwinyi, Jessica
- Naisbitt, Dean J.
- Nussler, Andreas K.
- Olinga, Peter
- Pampaloni, Francesco
- Pi, Jingbo
- Pluta, Linda
- Przyborski, Stefan A.
- Ramachandran, Anup
- Rogiers, Vera
- Schwarz, Michael
- Singh, Bijay
- Stelzer, Ernst H. K.
- Stieger, Bruno
- Sugiyama, Yuichi
- Vanhaecke, Tamara
- Vinken, Mathieu
- Weiss, Thomas S.
- Woods, Courtney G.
- Hengstler, Jan G.
- Venue
- Archives of Toxicology
- Published
- 2013-08
- Volume
- 87
- Issue
- 8
- Pages
- 1315-1530
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC3753504
- OpenAlex
- W2134520937
- Cited by
- 1,280
- References
- 1,862
- Citations by year
- 2026: 54 · 2025: 63 · 2024: 59 · 2023: 80 · 2022: 98 · 2021: 96 · 2020: 130 · 2019: 132 · 2018: 129 · 2017: 102 · 2016: 118 · 2015: 110 · 2014: 91 · 2013: 12
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Archives of Toxicology (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (submittedVersion, cc-by)
- HAL (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- University of Regensburg Publication Server (University of Regensburg)
- Funders
- Leibniz-Institut für Arbeitsforschung an der TU Dortmund
- Deutsche Forschungsgemeinschaft (GRK1104, (EXC 294))
- Agence Nationale de la Recherche
- Bundesministerium für Bildung und Forschung
- Belgian Federal Science Policy Office
- Fonds Wetenschappelijk Onderzoek
- National Research Foundation of Korea
- Innoviris
- Universität Regensburg
- Vlaamse regering
- National Institutes of Health (AA12916)
- Biotechnology and Biological Sciences Research Council (1233823)
- Leibniz-Gemeinschaft
- Japan Society for the Promotion of Science (23590204)
- National Institute on Alcohol Abuse and Alcoholism (R56AA012916, R01AA012916)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK070195)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- hepatotoxicity, primary hepatocytes, non-parenchymal liver cells, hepatocyte co-culture, precision-cut liver slices, isolated perfused liver, stem cell-derived hepatocytes, induced pluripotent stem cell-derived hepatocytes, nuclear receptors, Ras/MEK/ERK pathway, HNF4α, drug metabolism, ADME, drug interactions
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Liver, Inactivation, Metabolic, Organ Culture Techniques, Signal Transduction, Receptors, Cytoplasmic and Nuclear, Toxicity Tests, Coculture Techniques, Hepatocytes, Toxicogenetics, Culture Techniques, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review